News
Personalised blood test can detect risk of lung cancer relapse
17 Mar 2022
Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to Cambridge researchers.
Cambridge Festival 2022
2 Mar 2022
Bookings are now open for the Cambridge Festival which will take place from 30 March to 10 April, with hundreds of free events and activities for everyone.
Shining a light on mutational dark matter
4 Nov 2021
Researchers from our Early Detection Programme have discovered a way of measuring how many potentially cancer-causing mutations remain to be discovered across the human genome.
Foulkes Foundation Academy of Medical Sciences Medal
3 Nov 2021
Serena Nik-Zainal is awarded the 2021 Foulkes Foundation Medal: Paving the way to personalised cancer treatments.
Award for research on detecting cancer in primary care
14 Oct 2021
Dr Garth Funston and colleagues have won the 2020 Research Paper of the Year for Clinical Research, awarded by the Royal College of General Practitioners, for their paper on detecting cancers in primary care.
Discovery of liver cell mutations gives insight into causes of liver disease
13 Oct 2021
Mutations linking liver disease with obesity and diabetes have been identified, leading to new understanding about how systemic diseases interact.
The 2021 Don Listwin Award
7 Oct 2021
Congratulations to Rebecca Fitzgerald for being awarded the Don Listwin Award for Outstanding Contribution to Cancer Early Detection.
Francis Crick Medal and Lecture winner 2022
24 Aug 2021
Congratulations to Serena Nik-Zainal for being awarded The Francis Crick Medal and Lecture 2022.
Origin of oesophageal cancer cells revealed
12 Aug 2021
Discovery of origin of oesophageal cancer cells highlights importance of screening for pre-cancerous Barrett’s oesophagus.
Cytosponge adopted in Scotland
8 Jul 2021
NHS Scotland adopts the Cytosponge to diagnose and monitor people at risk of oesophageal cancer.